Differential dose effects of recombinant IL-25 on the development of dextran sulfate sodium-induced colitis

Inflammation Research

Volumn 59, Issue 10, 2010, Pages 879-887

  Salum McHenga, S S ^a   Wang, D ^a   Janneh, F M ^a   Feng, Y ^a   Zhang, P ^a   Li, Z ^a   Lu, C ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Acute colitis; Dose; DSS; IL 25; rIL 25

Indexed keywords

ANTIINFLAMMATORY AGENT; DEXTRAN SULFATE; GAMMA INTERFERON; GASTROINTESTINAL AGENT; INTERLEUKIN 10; INTERLEUKIN 25; INTERLEUKIN 4; PHOSPHATE BUFFERED SALINE; RECOMBINANT INTERLEUKIN 25; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIARRHEA; DISEASE SEVERITY; DOSE RESPONSE; DRUG MECHANISM; FEMALE; HISTOPATHOLOGY; MORTALITY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; REPEATED DRUG DOSE; ULCERATIVE COLITIS;

ANIMALS; COLITIS; COLON; DEXTRAN SULFATE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-4; INTERLEUKINS; KAPLAN-MEIER ESTIMATE; MICE; MICE, INBRED C57BL; RECOMBINANT PROTEINS;

EID: 77956917228     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-010-0200-x     Document Type: Article

References (28)

1. MM Fort J Cheung D Yen J Li SM Zurawski S Lo, et al. 2001 IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo Immunity 15 985 995 1:CAS:528:DC%2BD38Xhsl2ksA%3D%3D 10.1016/S1074-7613(01)00243-6 11754819 (Pubitemid 34075378)
2. SD Hurst T Muchamuel DM Gorman JM Gilbert T Clifford S Kwan, et al. 2002 New IL-17 family members promote Th1 or Th2 responses in the lung: In vivo function of the novel cytokine IL-25 J Immunol 169 443 453 1:CAS:528: DC%2BD38XltVKisLY%3D 12077275
3. G Pan D French W Mao M Maruoka P Risser J Lee, et al. 2001 Forced expression of murine IL-17E induces growth retardation, jaundice, a Th2-biased response, and multiorgan inflammation in mice J Immunol 167 6559 6567 1:CAS:528:DC%2BD3MXovVCiu78%3D 11714825
4. MR Kim R Manoukian R Yeh SM Silbiger DM Danilenko S Scully, et al. 2002 Transgenic overexpression of human IL-17E results in eosinophilia, B-lymphocyte hyperplasia, and altered antibody production Blood 100 2330 2340 1:CAS:528:DC%2BD38XnvVGis78%3D 10.1182/blood-2002-01-0012 12239140
5. P Angkasekwinai H Park YH Wang YH Wang SH Chang DB Corry, et al. 2007 Interleukin 25 promotes the initiation of proallergic type 2 responses J Exp Med 204 1509 1517 1:CAS:528:DC%2BD2sXnslymu7g%3D 10.1084/jem.20061675 17562814 (Pubitemid 47048018)
6. T Tamachi Y Maezawa K Ikeda S Kagami M Hatano Y Seto, et al. 2006 IL-25 enhances allergic airway inflammation by amplifying a TH2 cell-dependent pathway in mice J Allergy Clin Immunol 118 606 614 1:CAS:528:DC%2BD28XpsVWmtrg%3D 10.1016/j.jaci.2006.04.051 16950278 (Pubitemid 44301386)
7. T Benatar MY Cao Y Lee H Li N Feng X Gu, et al. 2008 Virulizin induces production of IL-17E to enhance antitumor activity by recruitment of eosinophils into tumors Cancer Immunol Immunother 57 1757 1769 1:CAS:528:DC%2BD1cXhtFCgu7vK 10.1007/s00262-008-0502-9 18351336
8. AM Owyang C Zaph EH Wilson KJ Guild T McClanahan HR Miller, et al. 2006 Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract J Exp Med 203 843 849 10.1084/jem.20051496 16606667
9. MA Kleinschek AM Owyang B Joyce-Shaikh CL Langrish Y Chen DM Gorman, et al. 2007 IL-25 regulates Th17 function in autoimmune inflammation J Exp Med 204 161 170 1:CAS:528:DC%2BD2sXhtFGjt74%3D 10.1084/jem.20061738 17200411 (Pubitemid 46148766)
10. PG Fallon SJ Ballantyne NE Mangan JL Barlow A Dasvarma DR Hewett, et al. 2006 Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion J Exp Med 203 1105 1116 1:CAS:528:DC%2BD28Xjsl2isb4%3D 10.1084/jem.20051615 16606668
11. P Alex NC Zachos T Nguyen L Gonzales TE Chen LS Conklin, et al. 2009 Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis Inflamm Bowel Dis 15 341 352 10.1002/ibd.20753 18942757
12. S Melgar A Karlsson E Michaëlsson 2005 Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation Am J Physiol Gastrointest Liver Physiol 288 G1328 G1338 1:CAS:528:DC%2BD2MXlsVyltL0%3D 10.1152/ajpgi.00467.2004 15637179 (Pubitemid 40741088)
13. B Egger M Bajaj-Elliott TT MacDonald R Inglin VE Eysselein MW Büchler 2000 Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency Digestion 62 240 248 1:CAS:528:DC%2BD3cXoslWju70%3D 10.1159/000007822 11070407
14. I Okayasu S Hatakeyama M Yamada T Ohkusa Y Inagaki R Nakaya 1990 A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice Gastroenterology 98 694 702 1:STN:280:DyaK3c7ivVSnuw%3D%3D 1688816
15. HS Cooper SN Murthy RS Shah DJ Sedergran 1993 Clinicopathologic study of dextran sulfate sodium experimental murine colitis Lab Invest 69 238 249 1:CAS:528:DyaK2cXhs1Smtr0%3D 8350599
16. SS Mchenga D Wang C Li F Shan C Lu 2008 Inhibitory effect of recombinant IL-25 on the development of dextran sulfate sodium-induced experimental colitis in mice Cell Mol Immunol 5 425 431 1:CAS:528:DC%2BD1MXhvV2it7w%3D 10.1038/cmi.2008.53 19118508
17. LG Axelsson E Landström AC Bylund-Fellenius 1998 Experimental colitis induced by dextran sulphate sodium in mice: beneficial effects of sulphasalazine and olsalazine Aliment Pharmacol Ther 12 925 934 1:CAS:528:DyaK1cXmtlOqsbY%3D 10.1046/j.1365-2036.1998.00357.x 9768537 (Pubitemid 28428959)
18. M Mähler IJ Bristol EH Leiter AE Workman EH Birkenmeier CO Elson, et al. 1998 Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis Am J Physiol 274 G544 G551 9530156
19. K Ikeda H Nakajima K Suzuki S Kagami K Hirose A Suto, et al. 2003 Mast cells produce interleukin-25 upon Fc epsilon RI-mediated activation Blood 101 3594 3596 1:CAS:528:DC%2BD3sXjs1aqtro%3D 10.1182/blood-2002-09-2817 12511410 (Pubitemid 36857947)
20. CM Kang AS Jang MH Ahn JA Shin JH Kim YS Choi, et al. 2005 Interleukin-25 and interleukin-13 production by alveolar macrophages in response to particles Am J Respir Cell Mol Biol 33 290 296 1:CAS:528:DC%2BD2MXhtVSkurjJ 10.1165/rcmb.2005-0003OC 15961726 (Pubitemid 41254296)
21. YH Wang P Angkasekwinai N Lu KS Voo K Arima S Hanabuchi A Hippe CJ Corrigan C Dong B Homey Z Yao S Ying DP Huston YJ Liu 2007 IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC activated Th2 memory cells J Exp Med 204 1837 1847 1:CAS:528:DC%2BD2sXptVyjsLo%3D 10.1084/jem.20070406 17635955 (Pubitemid 47236321)
22. R Ito M Shin-Ya T Kishida A Urano R Takada J Sakagami J Imanishi, et al. 2006 Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice Clin Exp Immunol 146 330 338 1:CAS:528:DC%2BD28XhtlCgtLfI 10.1111/j.1365-2249.2006.03214.x 17034586 (Pubitemid 44581349)
23. Y Xu NH Hunt S Bao 2008 The effect of restraint stress on experimental colitis is IFN-gamma independent J Neuroimmunol 200 53 61 1:CAS:528: DC%2BD1cXhtVKjurrL 10.1016/j.jneuroim.2008.06.008 18662832
24. J Horino M Fujimoto F Terabe S Serada T Takahashi Y Soma, et al. 2008 Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice Int Immunol 20 753 762 1:CAS:528:DC%2BD1cXmsFOit7Y%3D 10.1093/intimm/dxn033 18381351 (Pubitemid 351791519)
25. IJ Fuss M Boirivant B Lacy WT Strober 2002 he interrelated roles of TGF-beta and IL-10 in the regulation of experimental colitis J Immunol 168 900 908 1:CAS:528:DC%2BD38XksFWrtw%3D%3D 11777988
26. F Sanchez-Munoz A Dominguez-Lopez JK Yamamoto-Furusho 2008 Role of cytokines in inflammatory bowel disease World J Gastroenterol 14 4280 4288 1:CAS:528:DC%2BD1cXht1KrtbbF 10.3748/wjg.14.4280 18666314
27. S Melgar MM Yeung A Bas G Forsberg O Suhr A Oberg, et al. 2003 Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis Clin Exp Immunol 134 127 137 1:CAS:528:DC%2BD3sXos1Cks7c%3D 10.1046/j.1365-2249.2003.02268.x 12974765 (Pubitemid 37186598)
28. D Voehringer K Shinkai RM Locksley 2004 Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production Immunity 20 267 277 1:CAS:528:DC%2BD2cXis1Khtrk%3D 10.1016/S1074-7613(04)00026-3 15030771 (Pubitemid 38388229)